26 Participants Needed

Exercise Intervention for Cardiometabolic Health

(PACE Trial)

Recruiting at 1 trial location
JQ
MM
VN
Overseen ByVy Nguyen, B.S.
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Brigham and Women's Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team.

What data supports the effectiveness of the treatment Exercise Intervention for Cardiometabolic Health?

Research shows that exercise training can improve markers of exercise capacity, which is linked to better quality of life, especially for those with limited exercise capacity due to health issues. Additionally, exercise therapy has been shown to improve cardiometabolic risk factors and overall health outcomes in patients with cardiometabolic conditions.12345

Is exercise intervention generally safe for humans?

Exercise interventions are generally safe for humans, with few serious adverse events reported. Minor issues, like muscle injuries, can occur, especially in sedentary or older individuals, but starting slowly and gradually increasing intensity helps minimize risks. High-intensity exercise may have a slightly higher risk, so it should be done with caution and under supervision, especially for those with heart or metabolic conditions.678910

How does the exercise intervention treatment differ from other treatments for cardiometabolic health?

The exercise intervention treatment is unique because it focuses on improving cardiometabolic health through physical activity, which can enhance body composition, aerobic capacity, and blood glucose levels without the use of medication. Unlike traditional drug treatments, this approach leverages the body's natural responses to exercise, offering a non-invasive and holistic way to manage cardiometabolic conditions.511121314

What is the purpose of this trial?

The goal of this study is to understand the interaction between the circadian system and physical activity.Participants will:* complete 2 inpatient stays* perform moderate exercise* be provided with identical meals* have frequent blood draws* provide urine and saliva samples

Research Team

JQ

Jingyi Qian, PhD

Principal Investigator

Brigham and Women's Hospital

Eligibility Criteria

This trial is for healthy adults aged 20-45 with a BMI of 20-34.9, without any serious health issues like heart disease or cancer. Participants must be willing to follow the study's rules, including staying in the hospital and doing moderate exercise.

Inclusion Criteria

I do not have any serious long-term health conditions.
Body mass index (BMI) 20-34.9 kg/m2
Willing to adhere to the protocol requirements for the duration of the study
See 1 more

Exclusion Criteria

Any known contraindication to exercise testing based on current ACSM guidelines
Currently pregnant or breastfeeding
History of drug or alcohol dependency
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Inpatient Stay 1

Participants complete the first inpatient stay, perform moderate exercise, are provided with identical meals, and have frequent blood draws

1 week
1 inpatient visit

Inpatient Stay 2

Participants complete the second inpatient stay, perform moderate exercise, are provided with identical meals, and have frequent blood draws

1 week
1 inpatient visit

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Exercise intervention
Trial Overview The study aims to see how our body clocks affect physical activity by having participants stay twice in a clinic, do some exercise, eat set meals, and give blood, urine, and saliva samples for testing.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Exercise B-A InterventionExperimental Treatment1 Intervention
The Exercise B first, then the Exercise A intervention.
Group II: Exercise A-B InterventionExperimental Treatment1 Intervention
The Exercise A first, then the Exercise B intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Brigham and Women's Hospital

Lead Sponsor

Trials
1,694
Recruited
14,790,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

In a study of 192 obese patients undergoing a physical therapy and weight loss program, significant improvements were observed, including an average weight loss of 5.91 kg and a reduction in waist circumference by 7.1 cm, indicating effective weight management.
The program also led to enhanced exercise capacity (increased VO2ex by 5.29 ml/kg/min) and improved lower extremity function (LEFS increased by 9 points), along with reductions in blood pressure and fasting blood glucose, highlighting its positive impact on physical function and cardiometabolic health.
Improvements in cardiometabolic risk markers, aerobic fitness, and functional performance following a physical therapy weight loss program.Sabbahi, A., Arena, R., Woldt, J., et al.[2018]
Cardiac rehabilitation is crucial for patients with coronary heart disease, offering significant physiological, psychological, and prognostic benefits, and is structured into three phases: acute care, outpatient, and further conditioning programs.
Physical therapists play a vital role in implementing exercise testing and progressive activity programs, with data from Tufts New England Medical Center showing measurable improvements in cardiovascular health for these patients.
Cardiac rehabilitation. An overview.Hoskins, TA., Habasevich, RA.[2019]
Regular exercise significantly increases markers of exercise capacity, such as VO2max and ventilatory threshold (VT), which can enhance overall quality of life, especially for patients with health limitations.
Exercise serves as a positive health recommendation that not only improves physical fitness but may also indirectly encourage patients to adopt healthier behaviors, contrasting with traditional negative health advice.
Physical activity and exercise training prescriptions for patients.Foster, C., Cadwell, K., Crenshaw, B., et al.[2019]

References

Improvements in cardiometabolic risk markers, aerobic fitness, and functional performance following a physical therapy weight loss program. [2018]
Cardiac rehabilitation. An overview. [2019]
Physical activity and exercise training prescriptions for patients. [2019]
Exercise testing in cardiac rehabilitation. Exercise prescription and beyond. [2019]
Effectiveness of a Home-Based Telehealth Exercise Training Program for Patients With Cardiometabolic Multimorbidity: A Randomized Controlled Trial. [2021]
Adverse events among high-risk participants in a home-based walking study: a descriptive study. [2022]
Screening, safety, and adverse events in physical activity interventions: collaborative experiences from the behavior change consortium. [2022]
What Doesn't Kill You Makes You Fitter: A Systematic Review of High-Intensity Interval Exercise for Patients with Cardiovascular and Metabolic Diseases. [2022]
A randomized controlled trial of positive-affect induction to promote physical activity after percutaneous coronary intervention. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Adverse events in mobility-limited and chronically ill elderly adults participating in an exercise intervention study supported by general practitioner practices. [2015]
Resistance Training and High-intensity Interval Training Improve Cardiometabolic Health in High Risk Older Adults: A Systematic Review and Meta-anaylsis. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Effectiveness of a 12-week tele-exercise training program on cardiorespiratory fitness and heart rate recovery in patients with cardiometabolic multimorbidity. [2023]
13.United Statespubmed.ncbi.nlm.nih.gov
Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. [2023]
Evidence for prescribing exercise as therapy in chronic disease. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security